Serum Cytokine Measurement
Serum Cytokine Measurement - Related Videos
06:29
Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
0 Views •
Cited by 9 •
2011
We describe a simple immunoassay to measure the production of pro-inflammatory cytokines, such as IL-1 beta production, in patients presenting with autoinflammatory phenotypes. By activating cells in whole blood cultures with pathogen-associated molecular patterns, specifically with lipopolysaccharide, cytokine secretion can be conveniently evaluated in whole blood supernatants.
04:51
Measuring Immunoglobulin G Levels Against a Test Vaccine in a Mouse Serum
0 Views •
2025
This video demonstrates a method for assessing the antibody immune response to a novel nanoemulsion adjuvant vaccine in pre-immunized mice. Immunization enhances antibody response as confirmed by determining the IgG antibody titers.
08:26
Measuring the 50% Haemolytic Complement (CH50) Activity of Serum
0 Views •
Cited by 92 •
2010
The classical pathway is activated by antibody and culminates in target cell lysis. The CH50 assay provides a measure of the complement activity of a serum sample. This video demonstrates the steps involved in determining the CH50 of a serum sample, the calculations and interpreting of results.
12:58
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
0 Views •
Cited by 2 •
2017
Described here is a method for producing exogenous cytokine in patient-derived xenograft (PDX) mice via weekly intraperitoneal injection of a cytokine-transduced stromal cell line. This method broadens the utility of PDX and provides the option for transient or sustained exogenous cytokine delivery in a multitude of PDX models.
05:33
A Microneutralization Assay to Measure Neutralizing Antibody Titers in Human Serum
0 Views •
2025
This video demonstrates Microneutralization assays to measure neutralizing antibodies using Madin-Darby Canine Kidney cells overexpressing α2,6-linked sialic acid in human sera. This assay is often used for influenza human...
FAQs
Cytokine-specific antibodies provide the molecular selectivity needed to distinguish one immune signaling protein from another. In ELISA, target binding is linked to an enzyme-generated signal, whereas multiplex bead-based platforms use fluorescence. Known standards establish a calibration reference, allowing the measured signal to be converted into an estimated cytokine concentration rather than treated as a simple positive or negative finding.
ELISA and multiplex bead-based assays both rely on cytokine-specific antibody recognition, but they differ in the number of targets assessed within an assay. ELISA generates an enzyme-based signal for the measured target, while multiplex platforms use distinct bead-associated fluorescence to evaluate multiple cytokines. The platform choice therefore affects how broadly immune activity can be profiled.
Cytokine concentrations can change rapidly, so the time at which blood is obtained influences the immune snapshot represented by the serum. Sample handling also affects assay reliability, making consistent processing important when comparing individuals or serial samples. Without attention to timing and handling, observed differences may reflect collection conditions rather than meaningful changes in inflammation or immune activity.
Standards provide the reference needed to relate an enzyme- or fluorescence-based signal to a cytokine concentration. Assay performance must also remain reliable so that measured differences can be interpreted with confidence. Together, calibration and performance assessment support quantitative comparisons, which are essential when serum cytokine measurement is used to examine disease severity or response to treatment.
The workflow begins with whole-blood collection followed by separation of serum, the sample fraction used for testing. The serum is then analyzed with an antibody-based assay such as ELISA or a multiplex bead-based platform. Signals generated by target binding are compared with known standards, while careful control of handling, timing, and assay performance supports dependable measurements.
Medical studies can apply these measurements to infection, autoimmune disease, cancer, and inflammatory disorders. The results may help investigate systemic inflammation or broader immune activity and can be examined alongside disease severity or treatment response. Their value is greatest when researchers interpret concentrations in the context of controlled sampling and the known variability among individuals.
A serum cytokine profile provides information about circulating immune activity at the time of sampling. In medical research, concentrations may be evaluated as indicators associated with disease severity or as measurements that change during treatment response. Because cytokine levels vary between individuals and can shift quickly, results require careful timing and standardized handling before trends are interpreted.